Calvin Schmidt

Calvin Schmidt is currently a Senior Vice President at Johnson & Johnson. Over the course of his tenure at Johnson & Johnson, he has guided the company through critical milestones—including spearheading engagements with the White House and global heads of state during the COVID-19 pandemic and playing an instrumental role in guiding HLC’s policies on pandemic preparedness. During his time as President of Cardiovascular Metabolism (CVM) at Johnson & Johnson, Schmidt led a multi-disciplinary team that focused on continually driving positive impact for patients suffering from chronic conditions such as cardiovascular and metabolic diseases.